Simultaneous determination of phenazopyridine HCl and trimethoprim in presence of phenazopyridine HCl impurity by univariate and multivariate spectrophotometric methods - Quantification of phenazopyridine HCl impurity by univariate methods.

2,6-Diaminopyridine Partial Least Squares Phenazopyridine HCl Principle Component Regression Trimethoprim

Journal

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
ISSN: 1873-3557
Titre abrégé: Spectrochim Acta A Mol Biomol Spectrosc
Pays: England
ID NLM: 9602533

Informations de publication

Date de publication:
05 Oct 2020
Historique:
received: 02 03 2020
revised: 19 05 2020
accepted: 19 05 2020
pubmed: 4 6 2020
medline: 15 5 2021
entrez: 4 6 2020
Statut: ppublish

Résumé

Three univariate and two multivariate spectrophotometric methods were developed and subsequently validated to determine phenazopyridine HCl (PHZ) and trimethoprim (TMP) in the presence of 2,6-Diaminopyridine (2,6-DAP). The first univariate method depends on direct determination of phenazopyridine by measuring its absorbance at 412 nm and performed in concentration range of 1.00-10.00 μg/mL. Then the contribution of phenazopyridine is removed by dividing the mixture spectrum with PHZ divisor (5 μg/mL) after that the constant is mathematically subtracted and finally the generated spectrum is multiplied with the PHZ divisor. These steps eliminate PHZ contribution and the recovered spectrum is that of TMP and 2,6-DAP only where different methods can be applied to determine TMP and 2,6-DAP through this binary mixture spectrum. The first method to determine both components depends on measuring both TMP and 2,6-DAP through their first derivative (

Identifiants

pubmed: 32492634
pii: S1386-1425(20)30495-9
doi: 10.1016/j.saa.2020.118516
pii:
doi:

Substances chimiques

Trimethoprim AN164J8Y0X
Phenazopyridine K2J09EMJ52

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

118516

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Aya T Soudi (AT)

Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: aya.soudi@pharma.cu.edu.eg.

Ola G Hussein (OG)

Pharmaceutical Chemistry Department, Faculty of Pharmaceutical Science and Pharmaceutical Industries, Future University in Egypt, Cairo, Egypt.

Eman S Elzanfaly (ES)

Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.

Hala E Zaazaa (HE)

Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.

Mohamed Abdelkawy (M)

Pharmaceutical Chemistry Department, Faculty of Pharmaceutical Science and Pharmaceutical Industries, Future University in Egypt, Cairo, Egypt.

Articles similaires

Humans Machine Learning Lymphoma Spectroscopy, Fourier Transform Infrared Female
Surface Properties Toothpastes Ceramics Color Tooth Bleaching Agents
1.00
Humans Tooth Bleaching Hydrogen Peroxide Maxilla Incisor

Classifications MeSH